Funder
Global Health Innovative Technology Fund
Subject
Infectious Diseases,Parasitology
Reference31 articles.
1. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease;Urbina;Int. J. Antimicrob. Agents,2003
2. Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly;Tsukahara;Mol. Microbiol.,2003
3. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis;Hata;Antimicrob. Agents Chemother.,2011
4. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds;Miyazaki;Antimicrob. Agents Chemother.,2011
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献